Skip Navigation
Skip to contents

KDDW 2023


Scientific Program

Home    >    Program    >    Scientific Program

Member Societies

검색

Combined Symposium 02 (KPBA + KSGE) : Recent advances in endoscopic retrograde choangiopancreatography (ERCP) for surgically altered anatomy English

Date / Time Nov. 17 (Fri), 09:00-10:20
Room Walker 2
Chair(s) Jin Lee (Hallym University, Korea)
Dong-Wan Seo (University of Ulsan, Korea)
Speakers 09:00-09:20 Surgeons' advice: introduction to surgically altered anatomy Ho Seok Seo (The Catholic University of Korea, Korea)
09:20-09:40 Build-up of endoluminal insertion techniques for enteroscopy-assisted ERCP Chang Hwan Park (Chonnam National University, Korea)
09:40-10:00 EUS-guided antegrade intervention for surgically altered anatomy Hideyuki Shiomi (Hyogo Medical University , Japan)
10:00-10:20 ERCP-related adverse events in surgically altered anatomy Yuki Tanisaka (Saitama Medical University International Medical Center, Japan)

Combined Symposium 06 (KPBA + KSGE) : Malignant duodenal and biliary obstruction; various therapeutic strategy English

Date / Time Nov. 17 (Fri), 10:40-12:00
Room Walker 2
Chair(s) Jae Seon Kim (Korea University, Korea)
Ji Kon Ryu (Seoul National University, Korea)
Speakers 10:40-11:00 The survey result of treatment policy in combined malignant biliary and duodenal obstruction Dong Kee Jang (Seoul National University, Korea)
11:00-11:20 Pros and cons of endoscopic double stenting Hideyuki Shiomi (Hyogo Medical University , Japan)
11:20-11:40 Role of endoscopic ultrasonography guided procedure in combined malignant biliary and duodenal obstruction Se Woo Park (Hallym University, Korea)
11:40-12:00 Surgical bypass, when should be considered? Young Seok Han (Daegu Catholic University, Korea)

Free Paper 20: Pancreatobiliary 01 English

Date / Time Nov. 17 (Fri), 13:30-14:10
Room Walker 2
Chair(s) Kwang Bum Cho (Keimyung University, Korea)
Seong Woo Nam (National Medical Center, Korea)
Speakers 13:30-13:40 Impact of the Supra-papilla method on Patency in Distal Malignant Biliary Obstruction: A Multicenter Randomized Controlled Trial Sung Woo Ko (The Catholic University of Korea, Korea)
13:40-13:50 Long-term outcomes and factors affecting stent obstruction after endoscopic ultrasound-guided gallbladder drainage using electrocautery-enhanced lumen-apposing metal stent in inoperable patients with acute cholecystitis Jinwook Park (Soonchunhyang University, Korea)
13:50-14:00 Diagnostic Performance of Endoscopic Ultrasound Elastography for Differential Diagnosis of Gallbladder Polyp In Rae Cho (Seoul National University, Korea)
14:00-14:10 A short fully covered self-expandable metal stent for management of benign biliary stricture other than living-donor liver transplantation See Young Lee (Yonsei University, Korea)

Free Paper 21: Pancreatobiliary 02 English

Date / Time Nov. 17 (Fri), 14:10-14:50
Room Walker 2
Chair(s) Woojin Lee (National Cancer Center, Korea)
Seong Woo Park (Yonsei University, Korea)
Speakers 14:10-14:20 Impact of temperature-controlled endobiliary radiofrequency ablation on biliary drainage in patients with inoperable hilar cholangiocarcinoma: A randomized controlled trial Il Sang Shin (Soonchunhyang University, Korea)
14:20-14:30 The catheter flushing method increases the diagnostic yield of brushing cytology for biliary strictures Min Je Sung (CHA University, Korea)
14:30-14:40 Bile analysis in patients with biliary duct obstruction Si Eun Lee (Korea University, Korea)
14:40-14:50 Analysis of bile acid composition in recurrent bile duct gallstone patients Ki Hyun Ryu (Konyang University, Korea)

Free Paper 24: Pancreatobiliary 03 English

Date / Time Nov. 17 (Fri), 15:10-15:50
Room Grand 1
Chair(s) Young Koog Cheon (Konkuk University, Korea)
Seung Ok Lee (Jeonbuk National University, Korea)
Speakers 15:10-15:20 Dynamic ctDNAs Profiling as a Prognostic Biomarker in Pancreatic Cancer: a Large Prospective Cohort of 231 Patients Jinwoo Ahn (Seoul National University, Korea)
15:20-15:30 Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis Galam Leem (Yonsei University, Korea)
15:30-15:40 Prognosis prediction in pancreatic cancer according to methionyl-tRNA synthetase 1 expression levels by immunohistochemical staining See Young Lee (Yonsei University, Korea)
15:40-15:50 Prognostic value of TP53 mutation in Pancreatic ductal adenocarcinoma patients undergoing FOLFIRINOX. Min Kyu Kim (University of Ulsan, Korea)

Free Paper 25: Pancreatobiliary 04 English

Date / Time Nov. 17 (Fri), 15:50-16:30
Room Grand 1
Chair(s) Tae Hyeon Kim (Wonkwang University, Korea)
Seok Jeong (Inha University, Korea)
Speakers 15:50-16:00 Tailored aggressive hydration with lactated Ringers solution depending on the probability of post-ERCP pancreatitis is a safe and effective strategy Eunae Cho (Chonnam National University, Korea)
16:00-16:10 A population-based cohort study on risk factors for chronic pancreatitis: A comparison by age group Jin Myung Park (Kangwon National University, Korea)
16:10-16:20 Efficacy of an artificial neural network algorithm based on computed tomography (CT) images for the automated diagnosis of common bile duct stones Jae Keun Park (Hallym University, Korea)
16:20-16:30 Long term outcome of pancreatic cyst suspected branch-duct intrapapillary mucinous neoplasm: A single referral center experience Han Taek Jeong (Daegu Catholic University, Korea)
Supported by Member Societies
Associated Society
Supported by
Endorsed By
Diamond
Platinum
Gold
  • Silver
    Bronze+
    • 동아에스티
    Bronze
    • 길리어드
    • 유한양행
    • 삼성바이오에피스
    • 셀트리온제약(바이오마케팅팀)
    Sapphire+
    • 제일약품
    Sapphire
    • 일동제약
    • 한국에브비
    • 대원제약
    Crystal
    • BMS
    • 부광약품
    • 한미약품
    • 삼일제약
    • 종근당
    Pearl
    • 보령
    • SK케미칼
    • 녹십자웰빙
    • 안국약품
    • 유나이티드
    • 태준제약
    • 펜탁스메디컬
    • 건강약품
    • 에르베메디칼
    • 엠아이텍
    • 중외제약
    • 한국에자이
    • 일양약품
    • 스탠다드싸이텍
    • (주)한국로슈
    • 한국메나리니
    • 명문제약
    • 아이넥스코퍼레이션
    • GC녹십자
    • 조양메디컬
    • Naturlax
    • 파인메딕스
    • 하나제약

    Go to Top

    케이디디더블유 운영협의체

    Business License No.: 609-82-84671

    President: Jae Gyu Kim

    Tel.: 02-459-8252

    E-mail : kddwoffice@gmail.com

    Address : Room 305 Lotte Gold Rose Ⅱ, 31 Seolleung-ro 86 gil, Gangnam-gu, Seoul, 06193, Korea
    KDDW 2023 Secretariat
    Contact (Scientific Program & Abstract) kddwinfo@medioffice.or.kr
    (Registration & Sponsor) Email.kddw2023@medioffice.or.kr